March 5, 2019 / 10:31 PM / 6 months ago

GSK accuses Zofran plaintiffs' law firms of funding academic study

A lawyer for GlaxoSmithKline PLC on Tuesday accused plaintiffs’ lawyers of financially backing a study published last year reporting an increased risk of birth defects for children born to women who used the antinausea drug Zofran during pregnancy.

The claim made by Jennifer Hill, a lawyer for the drugmaker at Shook Hardy & Bacon, during a hearing in Boston federal court prompted a swift denial by one of the lead lawyers for hundreds of women who are suing GSK for failing to warn of Zofran’s risks.

To read the full story on WestlawNext Practitioner Insights, click here:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below